Optibiotix Health Share Discussion Threads

[manc10] 29/10/2018 09:35

rayrat the man who said lpldl wont get rid of eczema lol

[rafboy] 29/10/2018 09:32

LOL, and they appear on cue. Don’t know what you both have said as you are filtered.

[rayrac] 29/10/2018 09:30

Exactly, saul goodman! Nothing special offered.

[monkeywench1] 29/10/2018 09:29

Should be lol.

[rafboy] 29/10/2018 09:23

Good to see the share price rising. The detractors will be leaving soon, best ignored anyway.

[saul goodman] 29/10/2018 09:21

Its a POS.

Just another me too business in a fad market that is already saturated with dozens of competitors offering exactly the same products and services. None of them making a dime.

[riskybusiness1] 29/10/2018 09:20

Clearly on its way though wouldn't you agree? From multiple sources listed by parob below? Guess you have to understand how pre commercial companies like Opti transition, otherwise you get hung up on pre commercial revenue figures which any sensible investor would realise is not yet important. End of year there should be a visible jump in cash hitting the bottom line.

[saul goodman] 29/10/2018 09:14

#42655

100% margin?

LOL!

[monkeywench1] 29/10/2018 09:10

Lol so no revenues yet

[parob] 29/10/2018 09:08

The stock seems to have bottomed out! Recovery starts this week imo.

[riskybusiness1] 29/10/2018 08:59

LOL - revenues as explained and explained will come following now having the deals sequentially aligned from manufacturer, formulator to distributor. Each will have a lag between announcement and revenue as these partners come to market. Most importantly it's how profitable this revenue will be as it is 100% margin.

[manc10] 29/10/2018 07:47

Monkey why do you keep saying revenues when you said yourself revenues will be in 2019 not 2018 as soh stated many times break even 2018 year end

[judijudi] 29/10/2018 07:45

Rayrac
UGOT nowt is also a public bb
Your just a Troll
And a failed one at that
imho

[monkeywench1] 29/10/2018 07:42

Revenues so far?

[parob] 29/10/2018 07:42

ProBiotix Health (LP-LDL) deals so far:- Sacco- HLH BioPharma Vertriebs GmbH - Nutrilinia- Pharmabiota- Galenicum Special Ingredients - Fine Foods & Pharmaceuticals- Trigen Pharma- Akums Drugs and Pharma- Seed Health- Unnamed US pharma partner - Bened Biomedical- Unnamed Bulgarian CholBiome distributor - US Pharma Lab

[rayrac] 29/10/2018 07:39

But you are here guys! Are you privileged more than others, just because you claim to be holders of the shares? This thread is in a public place, open to all!

My trouble is, i find it very hard to believe that the products promoted here, work to the benefit of the public, especially as the idea of how the microbiome works, came from a man, SoH, who has no scientific background at all!

[judijudi] 28/10/2018 22:35

Nobby,
Exactly
Pot Kettle
What a pathetic post of rayracs, he is a goon
Funny
:)

[nobbygnome] 28/10/2018 19:01

But you are here....which is equally pathetic!

[rayrac] 28/10/2018 10:11

I see slartyfartfaster has been on the UKOG thread..how pathetic!

You do more harm, just, than LPLDL does to Opti. :)

[riskybusiness1] 27/10/2018 15:56

I wouldn't focus too much just yet on the online platform as it is the smallest commercial route to market with current resources. Opti is B2B mainly, using the online to showcase to corporates what Opti has on offer. It will also serve the UK market early before retailers get involved. As the online is direct to consumer it is higher value end product, however there is a cost of goods at around 40% margin. B2B is 100% margin and I would expect to see the beginning wave of this more important cash stream hitting the bottom line at year end. SOH recently gave an indication they are now 'covering costs on a month to month basis'. Fixed costs are around £65k-£95k per month. Depending on when they started covering monthly costs I'm expecting a visible jump in this type of revenue at year end. The value chain has been completed with more and more distributors now signing up, things should really start to shift in to profitability in to 2019 as was the stated expectations.Very exciting watching Opti develop these past years. The last round of director appointments of top class industry titans exemplifies the strengthening of the board in preparation for the next level. Really is a class operation which is why they have put in nearly £500k between them, all at a premium to today's prices.

[shrewdmole] 27/10/2018 13:34

Daz

Dont worry about second guessing numbers for now.

There are imho some very large number driven announcements to come soon.

We won’t be thinking about projections then.
In the meantime yes as new products and partners come on stream the revenues will grow nicely whilst the larger more corporate developments are being discussed.

[dazah] 27/10/2018 13:05

Good to see those orders, for sure current order rate is 100/month right now!!

So add that to all the existing payments that have been made we can guess what half year revenues are :)

Anyone care to pull a few numbers together?

[manc10] 27/10/2018 12:44

just out now shareprophets stonking sells for 2018/19 you have guessed it ukog lol

[rayrac] 27/10/2018 11:44

And revenues?! Looks like it’s ramping time.

LPLDL has got to prove itself. I’m very much inclined to think it’s a gimmick. The medical world would be jumping all over it if it were of use! 5% bp, and 13% cholesterol, are just not good enough.